BioStem Technologies Enters Into a Share Exchange Agreement
14 févr. 2023 08h55 HE
|
BioStem Technologies, Inc.
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15 nov. 2022 16h05 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
08 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
16 août 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results
01 avr. 2022 10h00 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...